1.86
price down icon2.36%   -0.05
after-market Handel nachbörslich: 1.86
loading

Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.83%
0.12
0.121 0.109 0.165 0.163
Operating Expenses
18.82%
12.09
14.90 14.49 12.77 12.71
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
18.82%
12.09
14.90 14.49 12.77 12.71
Operating Income/Loss
18.97%
-11.97
-14.78 -14.38 -12.60 -12.54
Nonoperating Income/Loss
14.15%
0.716
0.834 0.948 0.746 0.767
Income/Loss From Continuing Operations Before Tax
100.86%
0.12
-13.94 -13.43 0.165 -11.78
Income/Loss From Continuing Operations After Tax
19.26%
-11.26
-13.94 -13.43 -11.86 -11.78
Net Income/Loss
19.26%
-11.26
-13.94 -13.43 -11.86 -11.78
Preferred Stock Dividends And Other Adjustments
0.006
- - 0.006 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.53%
66.88
66.53 66.52 46.87 44.83
Diluted Average Shares
0.53%
66.88
66.53 66.52 46.87 44.83
Basic Earnings Per Share
19.05%
-0.17
-0.21 -0.20 -0.25 -0.26
Diluted Earnings Per Share
19.05%
-0.17
-0.21 -0.20 -0.25 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.006
- - 0.006 -
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):